top of page
Newsroom
April 10, 2020
FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agentas a Diagnostic for the Management of Eosinophilic Esophagitis
bottom of page
April 10, 2020
FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agentas a Diagnostic for the Management of Eosinophilic Esophagitis